Anavex Life Sciences Corp (AVXL)

[abew4me]

The shorts are desperate to cover because they've seen what can happen with SAVA. (It went from $11 to over $120 in just 10 days!)

So no, I haven't sold a single share...and don't plan on it because I know AVXL has a much bigger pipeline than SAVA. (Heck, SAVA is just a one-trick pony with a P2 AD trial behind it. That's it!)

Anavex has THREE P-3 trials for AD, RETT, and Parkinson's Disease...with RETT completion in the next 60 days or so!

Comparing AVXL to SAVA is like comparing an ELEPHANT to a mouse. THIS is why the shorts are desperate to get our shares in the low teens.

Don't sell to them because the share price will be MUCH HIGHER once the results are released for the P-3 Rett trial in the next 60 days.

I'm expecting at least $25/share by end of February...and $45/share after Rett results.

This is all just my opinion, of course. Do your own DD.

Abe